LIGHT-PSMA-CART cells
/ BRL Medicine
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
January 05, 2024
LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer
(clinicaltrials.gov)
- P1 | N=12 | Suspended | Sponsor: Bioray Laboratories | Trial completion date: Dec 2023 ➔ Oct 2024
Trial completion date • Castration-Resistant Prostate Cancer • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
January 27, 2023
LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer
(clinicaltrials.gov)
- P1 | N=12 | Suspended | Sponsor: Bioray Laboratories | Trial primary completion date: Nov 2022 ➔ Nov 2023
Trial primary completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
July 27, 2020
LIGHT-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer
(clinicaltrials.gov)
- P1; N=12; Recruiting; Sponsor: Shanghai Bioray Laboratory Inc.; Phase classification: P1/2 ➔ P1; Trial completion date: Aug 2022 ➔ Dec 2022; Initiation date: Aug 2019 ➔ Jul 2020; Trial primary completion date: Aug 2020 ➔ Jul 2021
Clinical • Phase classification • Trial completion date • Trial initiation date • Trial primary completion date • Genito-urinary Cancer • Oncology • Prostate Cancer • Solid Tumor
1 to 3
Of
3
Go to page
1